当前位置:首页 - 行情中心 - 千红制药(002550) - 财务分析 - 现金流量表

千红制药

(002550)

  

流通市值:63.51亿  总市值:85.23亿
流通股本:9.54亿   总股本:12.80亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金834,428,878.3432,825,600.521,704,076,524.071,277,800,881.7
  收到的税费返还258,059.38258,059.38-166,248.01
  收到其他与经营活动有关的现金32,019,010.7119,444,416.8231,293,035.3128,823,521.06
  经营活动现金流入小计866,705,948.39452,528,076.721,735,369,559.381,306,790,650.77
  购买商品、接受劳务支付的现金370,358,516.44152,629,339.64644,062,050.42521,798,617.19
  支付给职工以及为职工支付的现金130,389,300.1673,896,240.34212,059,651.55171,503,922.6
  支付的各项税费73,928,145.1830,574,817.04156,060,042.07111,197,617.8
  支付其他与经营活动有关的现金113,741,308.9357,168,482.13361,826,362.22210,943,759.46
  经营活动现金流出小计688,417,270.71314,268,879.151,374,008,106.261,015,443,917.05
  经营活动产生的现金流量净额178,288,677.68138,259,197.57361,361,453.12291,346,733.72
二、投资活动产生的现金流量:
  收回投资收到的现金--188,594,260.22-
  取得投资收益收到的现金10,373,010.346,402,504.5915,926,056.715,565,369.03
  处置固定资产、无形资产和其他长期资产收回的现金净额18,200-90,131.220
  收到的其他与投资活动有关的现金864,356,958.5436,458,997.44142,234,492.651,260,610,787.43
  投资活动现金流入小计874,748,168.84442,861,502.03346,844,940.791,276,176,156.46
  购建固定资产、无形资产和其他长期资产支付的现金78,410,430.0345,818,795.09141,604,595.5976,287,965.86
  投资支付的现金--45,905,638.89-
  支付其他与投资活动有关的现金988,666,016.43390,250,599.78321,675,825.351,341,390,324.21
  投资活动现金流出小计1,067,076,446.46436,069,394.87509,186,059.831,417,678,290.07
  投资活动产生的现金流量净额-192,328,277.626,792,107.16-162,341,119.04-141,502,133.61
三、筹资活动产生的现金流量:
  吸收投资收到的现金--24,500,00024,500,000
  其中:子公司吸收少数股东投资收到的现金--24,500,00024,500,000
  取得借款收到的现金29,999,799.5---
  收到其他与筹资活动有关的现金46,126,37546,126,3758,257,480-
  筹资活动现金流入小计76,126,174.546,126,37532,757,48024,500,000
  偿还债务支付的现金--20,000,00020,000,000
  分配股利、利润或偿付利息支付的现金189,207,241.67-150,434,116.81150,929,352.81
  支付其他与筹资活动有关的现金---0
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计189,207,241.67-170,434,116.81170,929,352.81
  筹资活动产生的现金流量净额-113,081,067.1746,126,375-137,676,636.81-146,429,352.81
四、汇率变动对现金及现金等价物的影响-6,158,312.92-1,915,895.88-13,051,061.63-4,075,986.45
五、现金及现金等价物净增加额-133,278,980.03189,261,783.8548,292,635.64-660,739.15
  加:期初现金及现金等价物余额488,238,035.65488,238,035.65439,945,400.01439,945,400.01
  期末现金及现金等价物余额354,959,055.62677,499,819.5488,238,035.65439,284,660.86
补充资料:
  净利润142,882,581.49-373,254,947.94-
  资产减值准备46,172.61--109,775,119.84-
  固定资产和投资性房地产折旧32,448,905.09-61,959,643.23-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧32,448,905.09-61,959,643.23-
  无形资产摊销1,787,677.33-3,748,884.62-
  长期待摊费用摊销2,079,142.38-3,907,896.92-
  处置固定资产、无形资产和其他长期资产的损失---14,356.7-
  固定资产报废损失103,123.54-96,718.91-
  公允价值变动损失-7,552,124.06--6,548,550.29-
  财务费用18,149,941.16-14,580,788.7-
  投资损失-4,351,641.43--11,592,371.35-
  递延所得税-3,381,236.71-9,489,991.27-
  其中:递延所得税资产减少-3,296,688.39-8,735,232.69-
    递延所得税负债增加-84,548.32-754,758.58-
  存货的减少-32,751,521.28-49,074,465.54-
  经营性应收项目的减少12,475,451.99--37,844,134.83-
  经营性应付项目的增加15,971,057.63-12,922,590.32-
  其他---2,090,515.29-
  现金的期末余额354,959,055.62-488,238,035.65-
  减:现金的期初余额488,238,035.65-439,945,400.01-
  现金及现金等价物的净增加额-133,278,980.03-48,292,635.64-
公告日期2026-08-082026-04-242026-04-242025-10-30
审计意见(境内)标准无保留意见
TOP↑